Long-term results of liver transplantation in patients 60 years of age and older

被引:101
作者
Collins, BH [1 ]
Pirsch, JD [1 ]
Becker, YT [1 ]
Hanaway, MJ [1 ]
Van der Werf, WJ [1 ]
D'Alessandro, AM [1 ]
Knechtle, SJ [1 ]
Odorico, JS [1 ]
Leverson, G [1 ]
Musat, A [1 ]
Armbrust, M [1 ]
Becker, BN [1 ]
Sollinger, HW [1 ]
Kalayoglu, M [1 ]
机构
[1] Duke Univ, Med Ctr, Div Transplantat, Dept Surg, Durham, NC 27710 USA
关键词
D O I
10.1097/00007890-200009150-00012
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Advances in perioperative care and immunosuppression have enabled clinicians to broaden the indications for organ transplantation. Advanced age is no longer considered a contraindication to transplantation at most centers. Although short-term studies of elderly liver transplant recipients have demonstrated that the incidence of complications and overall patient survival are similar to those of younger adults, transplant center-specific, long-term data are not available. Methods. From August of 1984 to September of 1997, 91 patients 60 years of age or older received primary liver transplants at the University of Wisconsin, Madison. This group of patients was compared with a group of younger adults (n=387) ranging in age from 18 to 59 years who received primary liver transplants during the same period. The most common indications for transplantation in both groups were Laennec's cirrhosis, hepatitis C, primary biliary cirrhosis, primary sclerosing cholangitis, and cryptogenic cirrhosis, There was no difference in the preoperative severity of illness between the groups. Results. The length of hospitalization was the same for both groups, and there were no significant differences in the incidence of rejection, infection (surgical or opportunistic), repeat operation, readmission, or repeat transplantation between the groups. The only significant difference identified between the groups was long-term survival. Five-year patient survival was 52% in the older group and 75% in the younger group (P<0.05), Ten-year patient survival was 35% in the older group and 60% in the younger group (P<0.05), The most common cause of late mortality in elderly liver recipients was malignancy (35.0%), whereas most of the young adult deaths were the result of infectious complications (24.2%), Conclusion. Although older recipients at this center did as well as younger recipients in the early years after liver transplantation, long-term survival results were not as encouraging.
引用
收藏
页码:780 / 783
页数:4
相关论文
共 16 条
[1]  
ARREAZA EE, 1993, CLIN EXP IMMUNOL, V92, P169
[2]   ORTHOTOPIC LIVER-TRANSPLANTATION IN PATIENTS OVER 60 YEARS OLD [J].
BROMLEY, PN ;
HILMI, I ;
TAN, KC ;
WILLIAMS, R ;
POTTER, D .
TRANSPLANTATION, 1994, 58 (07) :800-803
[3]  
CANTAROVICH D, 1994, TRANSPLANT INT, V7, P33, DOI 10.1007/BF00335661
[4]   PROGNOSTIC VALUE OF CHILD-TURCOTTE CRITERIA IN MEDICALLY TREATED CIRRHOSIS [J].
CHRISTENSEN, E ;
SCHLICHTING, P ;
FAUERHOLDT, L ;
GLUUD, C ;
ANDERSEN, PK ;
JUHL, E ;
POULSEN, H ;
TYGSTRUP, N .
HEPATOLOGY, 1984, 4 (03) :430-435
[5]  
EMRE S, 1993, TRANSPLANT P, V25, P1075
[6]   1-YEAR SURVEY OF PATIENTS WITH ADVANCED LIVER-CIRRHOSIS - PROGNOSTIC VALUE OF CLINICAL AND LABORATORY INDEXES IDENTIFIED BY THE COX REGRESSION-MODEL [J].
FERRO, D ;
SALIOLA, M ;
QUINTARELLI, C ;
ALESSANDRI, C ;
BASILI, S ;
CORDOVA, C ;
BONAVITA, MS ;
VIOLI, F .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1992, 27 (10) :852-856
[7]  
ISMAIL N, 1994, AM J KIDNEY DIS, V23, P1
[8]  
*NAT CTR HLTH STAT, 1998, US DEC LIF TABL 1989
[9]   IMMUNOSENESCENCE - AGING OF THE IMMUNE-SYSTEM [J].
PAWELEC, G ;
ADIBZADEH, M ;
POHLA, H ;
SCHAUDT, K .
IMMUNOLOGY TODAY, 1995, 16 (09) :420-422
[10]   CADAVERIC RENAL-TRANSPLANTATION WITH CYCLOSPORINE IN PATIENTS MORE THAN 60 YEARS OF AGE [J].
PIRSCH, JD ;
STRATTA, RJ ;
ARMBRUST, MJ ;
DALESSANDRO, AM ;
SOLLINGER, HW ;
KALAYOGLU, M ;
BELZER, FO .
TRANSPLANTATION, 1989, 47 (02) :259-261